Programme
The final programme in pdf format is now available to the right of the screen
Similar to last year, an ACTIVATE Skills Clinic will be organized by the EuropeHIVResistance project team. Registration runs through the www.EuropeHIVResistance.org website were you can download a registration form. For more information on the ACTIVATE Skills Clinic, please contact EHR project secretariat (info@europehivresistance.com). The preliminary program can be found on the right of the webpage in pdf format.
Confirmed speakers
-
Importance of treatment adherence - the clinician's perspective
Andrea De Luca, MD graduated in medicine in 1989 and specialized in Infectious Diseases in 1993. He is an assistant Professor of Infectious Diseases, at the Catholic University of Sacred Heart, Rome, Italy. He is also the Director, Infectious Diseases Clinic, University Hospital, Siena, Italy. ...
-
Switching ART due to toxicity in patients with suppressed viremia: virological perspective
Anna Maria Geretti, MD, PhD, Department of Virology, Royal Free Hospital and Royal Free and University College Medical School, London, UK.
-
Treatment of resistant TB in HIV infected patients
Andrea Gori, MD , was appointed Director of Division of Infectious Diseases at "San Gerardo" Hospital, University of Milano-Bicocca, Monza in 2007.
-
Clinical update on HIV drug resistance to Entry Inhibitors
Richard Harrigan, PhD, is the Director of Research Laboratories at the BC Centre for Excellence in HIV/AIDS. His work primarily focuses on HIV drug efficacy, drug resistance, and the human and viral parameters that influence HIV disease progression. ...
-
Future applications of full length HIV sequencing
Paul Kellam PhD, Wellcome Trust Sanger Institute, United Kingdom Dr Kellam is the Viral Genomics group leader and Senior Investigator at the Wellcome Trust Sanger Institute and a Professor of Viral Pathogenesis at UCL. ...
-
Influenza A resistance to antiviral therapy
Bruno Lina, MD, PhD, was born in 1961 in Lyon, and did his medical training in Lyon. He is the head of a hospital based laboratory of Virology as well as the head of the CNRS – Université de Lyon research laboratory ...
-
Clinical update on HIV Drug resistance to NNRTIs
Carlo F. Perno, MD, PhD, is a Professor of Virology at the University of Rome ‘Tor Vergata’, Italy, and Director of the Unit of Molecular Virology at the Tor Vergata University Hospital, Rome, Italy. ...
-
Clinical update on HIV drug resistance to Integrase Inhibitors
Jonathan M. Schapiro MD, is a Clinical Assistant Professor at Stanford University School of Medicine, Stanford, California, and the Director of the AIDS Service, National Hemophilia Center, at Sheba Medical Center, ...
-
Importance of treatment adherence - the patient's perspective
Alain Volny Anne currently works for the French AIDS NGO called Actions Traitements, as Editor in Chief for the newsletter InfoTraitements and as a trainer. In parallel, he is a member of the Board of Directors of the European AIDS Treatment Group (EATG). ...
-
Switching therapy due to toxicity in patients w. undetectable viral load–Clinician's view
Mike Youle, B Med Sci, MB ChB After qualifying at Sheffield Medical School, UK, Dr Mike Youle helped found the world-renowned Kobler Clinic in London in 1986 as Clinical Trials Co-ordinator. ...
